Library / Laws / 116th Congress / House Bills / H.R. 465
H.R. 465
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-01-10 | 19.5K | ⠃⠗⠋ |